Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme-Reference-Cited by-同舟云学术

Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme

Published:2019-04-30 Issue:6 Volume:8 Page:2897-2907
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhang Botao¹,Shen Rongfang¹,Cheng Shujun¹^ORCID,Feng Lin¹

Affiliation:

1. State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

CAMS Innovation Fund for Medical Sciences

Peking Union Medical College Graduate Student Innovation Fund

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2192

Reference31 articles.

1. Immunotherapy for cancer in the central nervous system: Current and future directions

2. Beta‐catenin signalling in glioblastoma multiforme and glioma‐initiating cells;Nager M;Chemother Res Pract,2012